跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
研究合併E1A基因和表皮生長因子受體酪氨酸激?抑制劑在三重陰性乳癌臨床前治療的嶄新策略(2/3)
Su, Chih-Ming
(PI)
衛生福利部雙和醫院
研究計畫
:
A - 政府部門
›
b - 國家科學及技術委員會
概覽
指紋
指紋
探索此專案觸及的研究主題。這些標籤是根據基礎獎勵/補助款而產生。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Immunology and Microbiology
Phosphotransferase
100%
Kinase
100%
Tyrosine
100%
Epidermal Growth Factor
100%
Preclinical Study
100%
Sensitization
58%
Biological Functions
16%
Breast Cancer Cell Line
16%
Therapeutic Target
16%
Neck
8%
Tumor Cell
8%
Gamma Urogastrone
8%
Signal Transduction
8%
Human Adenovirus 5
8%
Mediator
8%
Cancer Cell
8%
Antineoplastic Activity
8%
HER2/neu
8%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Receptor Tyrosine Kinase Inhibitors
100%
Epidermal Growth Factor Receptor
100%
Preclinical Study
100%
Sensitization
53%
Cancer Cell
23%
Biological Functions
15%
Molecular Mechanism
15%
Estrogen Receptor Alpha
7%
Anticancer
7%
Human Adenovirus 5
7%
Clinical Trial
7%
Signal Transduction
7%
Progesterone Receptor
7%
Animal Model
7%
Gene Linkage
7%
HER2/neu
7%
Receptor Tyrosine Kinase
7%
Antineoplastic Activity
7%
Mediator
7%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor Kinase Inhibitor
100%
Preclinical Study
100%
Triple Negative Breast Cancer
100%
Epidermal Growth Factor Receptor
76%
Estrogen Receptor Alpha
7%
Head and Neck Tumor
7%
Breast Cancer
7%
Progesterone Receptor
7%
Clinical Trial
7%
Epidermal Growth Factor Receptor 2
7%
Protein Tyrosine Kinase
7%
Human Adenovirus 5
7%
Gamma Urogastrone
7%
Anticarcinogen
7%